亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會(huì)員登錄|免費(fèi)注冊(cè)|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購物車
企業(yè)會(huì)員第1年

成都云希化工有限公司  

美容肽,多肽,美容原料,定制肽,醫(yī)藥中間體

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
聯(lián)系方式
  • 聯(lián)系人:陳
  • 電話:19150309904
  • 郵件:aileen@youngshechem.com
  • 微信:19150309904
  • QQ:1398029096
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應(yīng)產(chǎn)品 > 云希廠家直銷肉豆蔻酰四肽-6
云希廠家直銷肉豆蔻酰四肽-6
單價(jià) 10.00 / g對(duì)比
銷量 暫無
發(fā)貨 四川成都市付款后3天內(nèi)
庫存 10000g起訂1g
品牌 成都云希
INCI Myristoyl Tetrapeptide-6
外觀 白色粉末
功效 皮膚護(hù)理
過期 長(zhǎng)期有效
更新 2021-07-05 16:42
 
詳細(xì)信息

1.Basic information:

INCI name: Myristoyl Tetrapeptide-6

Reference: DermaPep A420, Dermapep Wrincare

Purity: >95%

Grade: cosmetic

Source: synthetic

Appearance: white powder

Sequence: 

Formulation: available for your reference, please contact us.

MSDS and COA: available for your reference, please contact us

Delivery: promptly from stock

Odor: no

Stability: stable

Solubility: soluble in water

Capacity: 600g per month

Appearance: white powder

 

2.Function 

1.Anti-aging for face and body

2.Increase of collagen synthesis

3.Providing exceptional anti-aging benefits

4.Anti-aging effect against environmental stimulus such as UV irradiation

 

3.Applications 

Myristoyl Tetrapeptide-6 can be incorporated in cosmetic formulations such as emulsions, oily sera, gels and creams for anti-aging and anti-wrinkle purpose. 

4.Usage: Myristoyl tetrapeptide-6 significantly increases the expression of type I procollagen and fibronectin, efficiently reduces fine lines and wrinkles and helps to maintain dermal thickness.

 Myristoyl tetrapeptide-6 Mimic peptide of TGF-β; acts like TGF-β and increases the expression of procollagen type I and fibronectin and prevents the formation of wrinkles and fine lines

©2025 成都云希化工有限公司 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:41470  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |